These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 37081394
1. A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification. Yang L, Wang YR, Mou ZQ, Xiong PF, Deng K, Wen J, Li J. BMC Gastroenterol; 2023 Apr 20; 23(1):131. PubMed ID: 37081394 [Abstract] [Full Text] [Related]
2. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs. Dai YY, Gao YP, Chen LX, Liu JS, Zeng C, Zhou JD, Wu HL. Front Genet; 2022 Apr 20; 13():930446. PubMed ID: 36110218 [Abstract] [Full Text] [Related]
3. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification. Yang C, Zhang L, Hao X, Tang M, Zhou B, Hou J. Curr Oncol; 2022 Dec 28; 30(1):430-448. PubMed ID: 36661684 [Abstract] [Full Text] [Related]
4. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation. Wang T, Zhou Z, Wang X, You L, Li W, Zheng C, Zhang J, Wang L, Kong X, Gao Y, Sun X. Front Genet; 2022 Dec 28; 13():929035. PubMed ID: 36081998 [Abstract] [Full Text] [Related]
5. Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma. Peng YL, Dong YF, Guo LL, Li MY, Liao H, Li RS. PLoS One; 2023 Dec 28; 18(8):e0289552. PubMed ID: 37535570 [Abstract] [Full Text] [Related]
6. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Cao J, Liang Y, Gu JJ, Huang Y, Wang B. Front Genet; 2022 Dec 28; 13():991162. PubMed ID: 36353118 [Abstract] [Full Text] [Related]
7. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma. Li Y, Zhao K, Wu R, Wang J, Wang Q, Xiong Q, Xie F, Lei H, Feng P. J Gastrointest Oncol; 2023 Jun 30; 14(3):1392-1411. PubMed ID: 37435203 [Abstract] [Full Text] [Related]
8. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Pan J, Huang Z, Lin H, Cheng W, Lai J, Li J. BMC Cancer; 2022 Nov 04; 22(1):1132. PubMed ID: 36333719 [Abstract] [Full Text] [Related]
9. Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma. Wang H, Shui X, Zhang Z, He M, Tai S, Lin Y. Transl Cancer Res; 2024 Jun 30; 13(6):2799-2811. PubMed ID: 38988942 [Abstract] [Full Text] [Related]
10. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC. Li R, Liu X, Deng K, Wang X. BMC Med Genomics; 2023 Aug 01; 16(1):179. PubMed ID: 37528384 [Abstract] [Full Text] [Related]
11. Transcriptome-Wide Dynamics of m7G-Related LncRNAs during the Progression from HBV Infection to Hepatocellular Carcinoma. Shi M, Zhu S, Sun L, Hu J, Li H, Dai W, Song N, Li M, Wu Y, Xu D, Guo T. Front Biosci (Landmark Ed); 2023 Dec 19; 28(12):339. PubMed ID: 38179760 [Abstract] [Full Text] [Related]
12. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. Zhao B, Fang F, Liao Y, Chen Y, Wang F, Ma Y, Wei C, Zhao J, Ji H, Wang D, Tang D. BMC Bioinformatics; 2023 Mar 19; 24(1):100. PubMed ID: 36935487 [Abstract] [Full Text] [Related]
13. Three molecular subtypes and a five-gene signature for hepatocellular carcinoma based on m7G-related classification. Yue Y, Tao J, An D, Shi L. J Gene Med; 2024 Jan 19; 26(1):e3611. PubMed ID: 37847055 [Abstract] [Full Text] [Related]
14. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer. Ren L, Yang X, Liu J, Wang W, Liu Z, Lin Q, Huang B, Pan J, Mao X. Cancer Cell Int; 2023 May 08; 23(1):85. PubMed ID: 37158958 [Abstract] [Full Text] [Related]
15. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma. Wei W, Liu C, Wang M, Jiang W, Wang C, Zhang S. Front Genet; 2022 May 08; 13():906496. PubMed ID: 35938009 [Abstract] [Full Text] [Related]
16. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K. World J Gastroenterol; 2019 Jan 14; 25(2):220-232. PubMed ID: 30670911 [Abstract] [Full Text] [Related]
17. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma. Yu ZL, Zhu ZM. Bioengineered; 2021 Dec 14; 12(1):1708-1724. PubMed ID: 33955330 [Abstract] [Full Text] [Related]
18. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma. Luo Y, Ye J, Wei J, Zhang J, Li Y. Mol Med Rep; 2020 Aug 14; 22(2):997-1007. PubMed ID: 32468063 [Abstract] [Full Text] [Related]
19. Construction and validation of a novel prognostic model for thyroid cancer based on N7-methylguanosine modification-related lncRNAs. Zhou Y, Dai X, Lyu J, Li Y, Bao X, Deng F, Liu K, Cui L, Cheng L. Medicine (Baltimore); 2022 Oct 21; 101(42):e31075. PubMed ID: 36281116 [Abstract] [Full Text] [Related]
20. N7-methylguanosine modification of lncRNAs in a rat model of hypoxic pulmonary hypertension: a comprehensive analysis. Wang H, Chen RB, Zhang SN, Zhang RF. BMC Genomics; 2022 Jan 07; 23(1):33. PubMed ID: 34996349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]